Content Type: Research Publications

An Overview of Vaccine Development, Approval, and Regulation, with Implications for COVID-19

March 15, 2026

Repurposing Existing Drugs for New Uses: A Cohort Study of the Frequency of FDA-Granted New Indication Exclusivities Since 1997

March 15, 2026

Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018

March 15, 2026

Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018

March 15, 2026

US Spending Associated with Transition From Daily to 3-Times-Weekly Glatiramer Acetate

March 15, 2026

Projected Spending for Brand-Name Drugs in English Primary Care Given US Prices: A Cross-Sectional Study

March 15, 2026

Understanding When Real World Data Can Be Used to Replicate A Clinical Trial: A Cross‐Sectional Study of Medications Approved in 2011

March 15, 2026

Reputation and Authority: The FDA and the Fight Over U.S. Prescription Drug Importation

March 15, 2026

Incentivizing Antibiotic Development: Why Isn’t the Generating Antibiotic Incentives Now (GAIN) Act Working?

March 15, 2026

Clinical Development Times for Biosimilars in the United States

March 15, 2026

Confidentiality Orders and Public Interest in Drug and Medical Device Litigation

March 15, 2026

Clinical Benefit and Cost of Breakthrough Cancer Drugs Approved By the US Food and Drug Administration

March 15, 2026